Dabigatran can cause eosinophilic pleural and pericardial effusion with blood eosinophilia. (8th August 2016)

• Record Type: Journal Article
• Authors: Voulgaris, Thanasis; Anevlavis, Stavros; Karpathiou, Georgia; Forest, Fabien; Koulelidis, Andreas; Froudarakis, Marios
• Is Part Of: Clinical respiratory journal. Volume 12:Number 2(2018)
• Page Start: 799
• Page End: 801
• Publication Date: 2016-08-08
• Subjects: dabigatran -- effusion -- eosinophilia -- pleura -- thoracoscopy; Respiratory organs -- Diseases -- Periodicals; Respiratory organs -- Periodicals; 616.24
• DOI: 10.1111/crj.12537
• Languages: English
• ISSNs: 1752-6981

Abstract

Abstract: Eosinophilic pleural effusions (EPE) account for 5%–8% of all exudative pleural effusions. A pleural effusion is defined as eosinophilic if it contains 10% or more eosinophils. We present the case of a 70‐year‐old man with EPE, blood eosinophilia and pericardial effusion due to dabigatran, a novel anti‐thrombin agent.